Drools

Sector: Retail (Pet Shop & Veterinary Clinic Business Plan &)  |  HQ: India  |  Founded: Not separately disclosed  |  Employees: Not separately disclosed

Listed as: Privately held  | 

Company overview

Drools operates in the retail segment of the Indian market, with a presence noted in the pet shop & veterinary clinic business plan & category. The company is among the recognised participants in this segment alongside other Indian and multinational players. Operations follow the standard Companies Act 2013 disclosure framework where Drools is incorporated as a private or public limited company under Indian law, with statutory audit, GST registration under the CGST Act 2017, and applicable sectoral compliance under FSSAI, BIS, MoEF, or sectoral regulators as relevant to the activity. The competitive set in pet shop & veterinary clinic business plan & includes pan-India brands, regional players, and multinational subsidiaries operating in India through wholly-owned or joint-venture structures.

Recent developments

April 2026

Drools has made a significant strategic pivot into the fresh pet food category, announcing an investment of ₹180 crore alongside a partnership with Tetra Pak [1][2][3][5][6]. This move marks the company's first entry into fresh pet food, positioning Drools as a pioneer in what the company considers an untapped market segment in India. The collaboration with Tetra Pak suggests a focus on advanced packaging and processing technology for the fresh category, distinguishing this initiative from its existing dry and wet pet food offerings.

Earlier in 2025, Drools received a strategic investment from Nestlé, underscoring institutional confidence in the company's growth trajectory [7]. Financial data from mid-2025 indicates cat food products account for approximately 40% of Drools' total revenue, highlighting the importance of feline nutrition in the company's product portfolio [8]. Combined with the fresh pet food expansion, these developments suggest Drools is actively diversifying its revenue streams while reinforcing its position as a leading player in India's growing pet food market.

Sources (7)

1. Drools enters fresh pet food with Rs 180 cr investment - BusinessLine · BusinessLine · Mon, 06 Apr 2026
2. Drools Unlocks Fresh Pet Food Category with Tetra Pak Tie-Up - IMPACT Magazine · IMPACT Magazine · Mon, 06 Apr 2026
3. Drools enters fresh pet food segment with Rs 180 crore investment and Tetra Pak partnership - bestmediainfo.com · bestmediainfo.com · Mon, 06 Apr 2026
4. Retail India News: Drools Invests Rs 180 Cr to Enter Fresh Pet Food Category - Indian Retailer · Indian Retailer · Mon, 06 Apr 2026
5. Drools pioneers fresh pet food category in India with ₹180 crore investment and collaboration with Tetra Pak - Passionate In Marketing · Passionate In Marketing · Mon, 06 Apr 2026
6. Nestle invests in Indian pet food brand Drools - PetfoodIndustry · PetfoodIndustry · Tue, 27 May 2025
7. Cat Food Makes Up 40% Revenue For Dog Food Unicorn Drools - Inc42 · Inc42 · Fri, 25 Jul 2025

Financial performance and recent trajectory

Disclosed revenue (FY25): Not separately disclosed in segment-wise FY 2024-25 reporting.

Competitive position

Drools occupies a position in the pet shop & veterinary clinic business plan & category alongside other listed and unlisted Indian players. Competitive intensity in the segment is shaped by raw material cost cycles, distribution depth, branded versus unbranded share, and the regulatory framework governing manufacturing, FSSAI labelling (for food), BIS standards (for engineering goods), or sectoral norms. The principal competitive moats in this category are typically scale, distribution reach, brand trust, and integrated procurement. KAMRIT's project report on pet shop & veterinary clinic business plan & benchmarks new entrant economics against the listed peer cost structure including capex per tonne (or per unit of output), working capital intensity, gross margin band, and the EBITDA delta between organised and unorganised participants.

Key risks

Input cost volatility in the pet shop & veterinary clinic business plan & value chain Competitive intensity from larger Indian groups and multinational subsidiaries Regulatory tightening under FSSAI, BIS, environmental norms, or labour codes

Outlook

Drools is a participant in the Indian pet shop & veterinary clinic business plan & category, which forms part of the broader Retail space. The Indian pet shop & veterinary clinic business plan & market continues to evolve with rising organised share, premiumisation, distribution expansion, and a regulatory architecture covering the Companies Act 2013, the Income Tax Act 1961, the CGST Act 2017, the Legal Metrology Act 2009, and sectoral statutes including the Food Safety and Standards Act 2006 (for food and beverage subsegments), the Drugs and Cosmetics Act 1940 (for pharmaceutical or healthcare adjacencies), the Environment Protection Act 1986 (for emissions and effluents), and labour codes consolidated under the four 2020 labour codes. In KAMRIT's project report framework for this category, the competitive set typically includes pan-India branded leaders, multinational subsidiaries, mid-sized regional players, and a long tail of MSME participants. The structural attractiveness of the category for new entrants is a function of (a) market growth rate, (b) the share that remains with unorganised or fragmented operators, (c) the cost of regulatory compliance, and (d) the capex intensity of plant and machinery. The KAMRIT bankable DPR for this category structures a new entrant's economics against this competitive landscape. For Drools specifically, public-domain disclosures provide a baseline view of operations, but segment-wise revenue, EBITDA, capacity utilisation, and forward capex plans are not separately broken out in many cases. Where the company is part of a listed group, the SEBI LODR and the Companies Act 2013 governance framework apply, with statutory audit conducted under SA 700 and CARO 2020 reporting. Where the company is unlisted, the Companies Act 2013 framework continues to govern with reduced public disclosure. The risk and opportunity outlook for Drools mirrors the broader pet shop & veterinary clinic business plan & category dynamics. Demand-side drivers include rising household consumption, urbanisation, organised retail expansion, and policy support including PLI schemes (where applicable to the segment). Supply-side risks include input cost volatility, regulatory tightening, environmental compliance escalation, and competitive intensity from larger groups or imports. Management quality, balance sheet strength, distribution depth, and the capex execution track record are the differentiators within the peer set. KAMRIT's research desk maintains a baseline reference for Drools as a peer benchmark within the pet shop & veterinary clinic business plan & category. For investors, lenders, or new entrant promoters seeking a fuller assessment of Drools, KAMRIT's deep-dive company profile engagement covers financial trajectory, capacity and capex, distribution and customer concentration, regulatory exposure, and the competitive position with named peers.

KAMRIT point of view

Building or competing with Drools?

KAMRIT advises promoters, family offices, and global enterprises evaluating greenfield entry into the retail (pet shop & veterinary clinic business plan &) sector. Our Bankable DPR with Cost Model and ROI benchmarks your project economics against the listed-company cost structure of Drools and peers. The Execution Partnership tier covers everything from incorporation through commissioning. A 20-minute scoping call with our partners is free.

View all 1 related project report → Book a scoping call

Related KAMRIT project reports

These reports use Drools in benchmarking and competitive analysis sections.

Disclaimer: This profile is compiled by KAMRIT Financial Services LLP for educational and benchmarking purposes only. It is not investment advice, a recommendation to buy or sell securities, or a solicitation. Stock data is provided by Yahoo Finance and may be delayed by up to 20 minutes. Company financial commentary draws on publicly available filings, exchange disclosures, and KAMRIT industry research. Readers should consult a SEBI-registered investment adviser before making investment decisions. KAMRIT is a financial services and compliance firm, not a SEBI-registered investment adviser.